Gene therapy and other novel treatment approaches for Charcot-Marie-Tooth disease

遗传增强 髓鞘 医学 基因沉默 癌症研究 RNA干扰 生物信息学 基因 生物 遗传学 内科学 核糖核酸 中枢神经系统
作者
Chiara Pisciotta,Davide Pareyson
出处
期刊:Neuromuscular Disorders [Elsevier BV]
卷期号:33 (8): 627-635 被引量:29
标识
DOI:10.1016/j.nmd.2023.07.001
摘要

There is still no effective drug treatment available for Charcot-Marie-Tooth disease (CMT). Current management relies on rehabilitation therapy, surgery for skeletal deformities, and symptomatic treatment. The challenge is to find disease-modifying therapies. Several approaches, including gene silencing (by means of ASO, siRNA, shRNA, miRNA, CRISPR-Cas9 editing), to counteract the PMP22 gene overexpression in the most frequent CMT1A type are under investigation. PXT3003 is the compound in the most advanced phase for CMT1A, as a second phase-III trial is ongoing. Gene therapy to substitute defective genes (particularly in recessive forms associated with loss-of-function mutations) or insert novel ones (e.g., NT3 gene) are being developed and tested in animal models and in still exceptional cases have reached the clinical trial phase in humans. Novel treatment approaches are also aimed at developing compounds acting on pathways important for different CMT types. Modulation of the neuregulin pathway determining myelin thickness is promising for both hypo-demyelinating and hypermyelinating neuropathies; intervention on Unfolded Protein Response seems effective for rescuing misfolded myelin proteins such as MPZ in CMT1B. HDAC6 inhibitors improved axonal transport and ameliorated phenotypes in different CMT models. Other potential therapeutic strategies include targeting macrophages, lipid metabolism, and Nav1.8 sodium channel in demyelinating CMT and the P2×7 receptor, which regulates calcium influx into Schwann cells, in CMT1A. Further approaches are aimed at correcting metabolic abnormalities, including the accumulation of sorbitol caused by biallelic mutations in the sorbitol dehydrogenase (SORD) gene and of neurotoxic glycosphingolipids in HSN1.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
yuyu完成签到 ,获得积分10
1秒前
1秒前
挚友发布了新的文献求助10
3秒前
小橘子完成签到,获得积分10
3秒前
4秒前
4秒前
黄毛虎发布了新的文献求助10
4秒前
214完成签到,获得积分20
4秒前
5秒前
麒麟才子完成签到,获得积分10
5秒前
觉皇完成签到,获得积分10
5秒前
充电宝的应助被hhhhhhh采纳,获得10
5秒前
相看两厌完成签到,获得积分10
6秒前
吴境发布了新的文献求助10
6秒前
7秒前
7秒前
syvshc的应助被皮卡丘采纳,获得10
7秒前
8秒前
carbon发布了新的文献求助10
8秒前
8秒前
Cat完成签到,获得积分0
9秒前
Mars发布了新的文献求助10
9秒前
KDshyking完成签到,获得积分10
9秒前
KKK完成签到 ,获得积分10
10秒前
dean完成签到,获得积分10
10秒前
腼腆的虔纹完成签到,获得积分20
10秒前
10秒前
哟呵完成签到,获得积分0
11秒前
11秒前
烟花的应助被王淼采纳,获得30
12秒前
柚子完成签到,获得积分10
12秒前
墨之默完成签到,获得积分10
12秒前
12秒前
顾矜的应助被Bubble采纳,获得10
13秒前
13秒前
YXH发布了新的文献求助10
13秒前
14秒前
爽飞边芷了完成签到,获得积分10
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187480
求助须知:如何正确求助?哪些是违规求助? 9575554
关于积分的说明 21841909
捐赠科研通 7785230
什么是DOI,文献DOI怎么找? 3434949
关于科研通互助平台的介绍 2559412
邀请新用户注册赠送积分活动 2481898